Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Filipendula glaberrima Nakai extract inhibits the bacterial infection by induction of HBD2 and HBD3 expression, and reduction of the inflammatory activity. | Microbiol Immunol | 2023 | 37525428 | PubTator, text mining | PubMed |
| The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity. | Skin Res Technol | 2023 | 37522491 | PubTator, text mining | PubMed |
| Editorial: Global excellence in molecular immunology and therapeutics: Africa 2021. | Front Immunol | 2023 | 37520543 | PubTator, text mining | PubMed |
| Antimicrobial and Defense Proteins in Chronic Rhinosinusitis with Nasal Polyps. | Medicina (Kaunas) | 2023 | 37512070 | PubTator, text mining | PubMed |
| Crosstalk between the Resident Microbiota and the Immune Cells Regulates Female Genital Tract Health. | Life (Basel) | 2023 | 37511906 | PubTator, text mining | PubMed |
| Epigenetic Reader Bromodomain-Containing Protein 4 in Aging-Related Vascular Pathologies and Diseases: Molecular Basis, Functional Relevance, and Clinical Potential. | Biomolecules | 2023 | 37509171 | PubTator, text mining | PubMed |
| Antimicrobial Peptides and Interleukins in Cleft Soft Palate. | Children (Basel) | 2023 | 37508659 | PubTator, text mining | PubMed |
| The Emerging Role of Innate Lymphoid Cells (ILCs) and Alarmins in Celiac Disease: An Update on Pathophysiological Insights, Potential Use as Disease Biomarkers, and Therapeutic Implications. | Cells | 2023 | 37508573 | PubTator, text mining | PubMed |
| Enhanced Polyphenols Recovery from Grape Pomace: A Comparison of Pressurized and Atmospheric Extractions with Deep Eutectic Solvent Aqueous Mixtures. | Antioxidants (Basel) | 2023 | 37507983 | PubTator, text mining | PubMed |
| A Review of Existing and New Treatments for the Management of Hand Eczema. | J Cutan Med Surg | 2023 | 37496489 | PubTator, text mining | PubMed |
| First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma. | Mol Cancer Ther | 2023 | 37486983 | PubTator, text mining | PubMed |
| Chimeric vaccine design against the epidemic Langya Henipavirus using immunoinformatics and validation via immune simulation approaches. | Heliyon | 2023 | 37484358 | PubTator, text mining | PubMed |
| Importance of PLD2 in an IL-23 driven psoriasiform dermatitis model and potential link to human psoriasis. | J Dermatol | 2023 | 37455419 | PubTator, text mining | PubMed |
| The complete and fully-phased diploid genome of a male Han Chinese. | Cell Res | 2023 | 37452091 | PubTator, text mining | PubMed |
Effect of a Probiotic and a Synbiotic on Body Fat Mass, Body Weight and Traits of Metabolic Syndrome in Individuals with Abdominal Overweight: A Human, Double-Blind, Randomised, Controlled Clinical Study. | Nutrients | 2023 | 37447365 | PubTator, text mining | PubMed |
| Molecular Dynamics Simulations Combined with Markov Model to Explore the Effect of Allosteric Inhibitor Binding on Bromodomain-Containing Protein 4. | Int J Mol Sci | 2023 | 37446009 | PubTator, text mining | PubMed |
| Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis? | Int J Mol Sci | 2023 | 37445645 | PubTator, text mining | PubMed |
| Association between long-term exposure to ambient air pollutants and the risk of tuberculosis: A time-series study in Nantong, China. | Heliyon | 2023 | 37441410 | PubTator, text mining | PubMed |
| Human β-defensins are correlated with the immune infiltration and regulated by vitamin D3 in periodontitis. | J Periodontal Res | 2023 | 37439265 | PubTator, text mining | PubMed |
| Prognostic Impact of Tumor Budding on Moroccan Gastric Cancer Patients. | Clin Pathol | 2023 | 37426068 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=17